
BIMINI Biotech
BIMINI Biotech is a Leiden-based preclinical biotech company developing first-in-class small-molecule modulators of the Wiskott–Aldrich Syndrome protein (WASp) for hematological cancers and autoimmune diseases. The company focuses on targeting actin





































